Advertisement

Topics

Poxel reports positive results from PXL770 phase 1b MAD trial and drug─drug interaction study

15:53 EDT 19 Jul 2018 | PharmaBiz

POXEL SA, a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes and non─alcoholic steatohepatitis (NASH), has announced favorable

Related Biotechnology, Pharmaceutical and Healthcare News

Original Article: Poxel reports positive results from PXL770 phase 1b MAD trial and drug─drug interaction study

NEXT ARTICLE

More From BioPortfolio on "Poxel reports positive results from PXL770 phase 1b MAD trial and drug─drug interaction study"

Advertisement

Quick Links
Advanced Search | Login | Subscribe | RSS

Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...


News Quicklinks

Search Biotech, Medical and Healthcare News

Popular Biotech, Medical and Healthcare News

Biotech News by Article Type

BioPortfolio Bloggers

Publishing Your News on BioPortfolio

Recent Visitor News Searches

BioPortfolio Limited Social Media
Publish Content Agreements
Tools Help

HON Code certificate This site complies with the HONcode standard for trustworthy health information:
Verify here.

The information provided by BioPortfolio.com is not a substitute for professional medical advice, diagnosis or treatment. The BioPortfolio site is sponsored BioPortfolio Limited with offices at Stafford House, 10 Prince of Wales Road, Dorchester, DT1 1PW, England. If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of “Fair Use” and legitimately infringes on your or your client's copyright we may be contacted concerning copyright matters here: Contact BioPortfolio.
All rights reserved. All other trademarks recognized. Copyright © 1997-2019 BioPortfolio Limited. Site developed by Alacrify Ltd.